Workflow
IRAY TECHNOLOGY(688301)
icon
Search documents
奕瑞科技(688301) - 奕瑞科技第三届监事会第十五次会议决议公告
2025-09-12 13:30
| 证券代码:688301 | 证券简称:奕瑞科技 公告编号:2025-061 | | --- | --- | | 转债代码:118025 | 转债简称:奕瑞转债 | 奕瑞电子科技集团股份有限公司 第三届监事会第十五次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 2025 年 9 月 12 日,奕瑞电子科技集团股份有限公司(以下简称"公司") 以现场及通讯方式召开了第三届监事会第十五次会议(以下简称"本次会议"), 会议通知已于 2025 年 9 月 10 日以电子邮件形式发出。本次会议由监事会主席丰 华先生主持,会议应出席监事 3 人,实际出席并表决的监事 3 人。本次会议的召 开及表决程序符合《中华人民共和国公司法》(以下简称"《公司法》")等相关法 律、法规以及《奕瑞电子科技集团股份有限公司章程》(以下简称"《公司章程》") 的有关规定。 数量调整为 14.3237 万股,授予价格由 88.27 元/股调整为 62.34 元/股。 具体内容详见公司于同日在上海证券交易所网站(w ...
奕瑞科技(688301) - 奕瑞科技第三届董事会第十八次会议决议公告
2025-09-12 13:30
| 证券代码:688301 | 证券简称:奕瑞科技 公告编号:2025-060 | | --- | --- | | 转债代码:118025 | 转债简称:奕瑞转债 | 经审议,董事会认为:公司本次对限制性股票授予数量及授予价格的调整符 合《上市公司股权激励管理办法》及公司《2021 年限制性股票激励计划(草案)》 中关于授予数量及授予价格调整方法的规定,本次调整事项在公司 2021 年第一 次临时股东大会授权董事会决策的事项范围内,本次授予数量及授予价格调整合 法、有效。我们同意公司本次对 2021 年限制性股票激励计划授予数量及授予价 格进行调整。 具体内容详见公司于同日在上海证券交易所网站(www.sse.com.cn)披露的 《奕瑞电子科技集团股份有限公司关于调整 2021 年限制性股票激励计划授予数 量及授予价格的公告》(公告编号:2025-062)。 表决结果:6 票同意,0 票反对,0 票弃权。关联董事 Tieer Gu、Richard Aufrichtig 回避表决。 (二)审议通过《关于公司 2021 年限制性股票激励计划预留授予部分第三 个归属期符合归属条件的议案》 二、董事会会议审议情况 ...
奕瑞科技:9月12日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-09-12 13:28
Group 1 - The company, Yirui Technology, announced the convening of its 18th meeting of the third board of directors on September 12, 2025, to review proposals including the authorization for the issuance of A-shares to specific targets for the year 2024 [1] - For the fiscal year 2024, the revenue composition of Yirui Technology is as follows: digital X-ray detectors account for 93.53% and other businesses account for 6.47% [1] - As of the report date, Yirui Technology has a market capitalization of 22.3 billion yuan [1]
奕瑞科技(688301) - 奕瑞科技关于持股5%以上股东权益变动触及1%刻度的提示性公告
2025-09-08 10:47
重要内容提示: | 权益变动方向 | 比例增加□ | | 比例减少 | ☑ | | --- | --- | --- | --- | --- | | 权益变动前合计比例 | 8.66% | | | | | 权益变动后合计比例 | 7.66% | | | | | 本次变动是否违反已作出的承诺、 | 是□ | 否☑ | | | | 意向、计划 | | | | | | 是否触发强制要约收购义务 | 是□ | 否☑ | | | | 证券代码:688301 | 证券简称:奕瑞科技 | 公告编号:2025-059 | | --- | --- | --- | | 转债代码:118025 | 转债简称:奕瑞转债 | | 奕瑞电子科技集团股份有限公司 关于持股 5%以上股东权益变动触及 1%刻度的 提示性公告 持股 5%以上股东天津红杉聚业股权投资合伙企业(有限合伙)及其一致行 动人北京红杉信远股权投资中心(有限合伙)保证向本公司提供的信息真实、准 确、完整,没有虚假记载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 二、 权益变动触及 1%刻度的基本情况 2025 年 9 月 5 ...
奕瑞科技(688301.SH):天津红杉、北京红杉合计减持1.00%公司股份
Ge Long Hui A P P· 2025-09-08 10:33
格隆汇9月8日丨奕瑞科技(688301.SH)公布,2025年9月5日,公司收到股东天津红杉聚业股权投资合伙 企业(有限合伙)(以下简称"天津红杉")及其一致行动人北京红杉信远股权投资中心(有限合伙)(以下简 称"北京红杉",天津红杉、北京红杉合称为"信息披露义务人")发来的《关于奕瑞科技权益变动情况的 告知函》。2025年9月5日,天津红杉、北京红杉通过大宗交易的方式合计减持公司股份2,002,184股,占 公司总股本比例为1.00%,合计持有公司股份数量从17,333,169股减少至15,330,985股,持有公司股份比 例从8.66%减少至7.66%,权益变动触及1%刻度。 ...
每周股票复盘:奕瑞科技(688301)拟募资不超11.74亿元
Sou Hu Cai Jing· 2025-09-06 20:34
Core Points - Yirui Technology (688301) closed at 114.81 yuan on September 5, 2025, down 4.88% from last week's 120.7 yuan [1] - The company's current market capitalization is 22.987 billion yuan, ranking 9th out of 126 in the medical device sector and 805th out of 5152 in the A-share market [1] Trading Information - On September 5, Yirui Technology recorded a large transaction of 222 million yuan [3] Company Announcements - Yirui Technology plans to issue A-shares to specific investors, raising no more than 1.1736 billion yuan for the construction of X-ray vacuum devices and comprehensive solutions [1] - The number of shares to be issued will not exceed 15% of the total share capital before issuance, amounting to no more than 30,032,755 shares [1] - The issuance has been approved by the board of directors, the shareholders' meeting, and has received regulatory approval from the Shanghai Stock Exchange and the China Securities Regulatory Commission [1]
25只科创板股今日大宗交易平台发生交易
Summary of Key Points Core Viewpoint - On September 5, a total of 25 stocks from the STAR Market experienced block trades, with a cumulative transaction amount of 865 million yuan, indicating active trading in the sector [2]. Group 1: Trading Activity - There were 67 block trades executed, with a total trading volume of 15.79 million shares [2]. - The stock with the highest transaction amount was Yirui Technology, which had 2 block trades totaling 2.22 million yuan [2]. - Other notable stocks in terms of transaction amounts included Lide Harmony and Tonglian Precision, with transaction amounts of 1.28 billion yuan and 1.09 billion yuan, respectively [2]. Group 2: Price and Discount Analysis - The stocks that experienced the highest discount rates relative to their closing prices included Tonglian Precision, Oat Technology, and Zhongchuang Co., with discount rates of 30.47%, 22.49%, and 21.56% respectively [2]. - The average increase for the stocks involved in block trades was 5.29%, with the STAR 50 Index rising by 3.39% on the same day [2]. Group 3: Institutional Participation - Among the block trades, 12 transactions involved institutional buyers or sellers, covering 8 stocks [2]. - The leading stocks in terms of institutional buying were Ailis, Artis, and New Zhisoft, with respective amounts of 29.49 million yuan, 21.14 million yuan, and 10.98 million yuan [2]. Group 4: Fund Flow - Out of the stocks involved in block trades, 12 experienced net inflows from major funds, with the highest net inflows recorded for Borui Pharmaceutical, Huasheng Lithium, and New Zhisoft, amounting to 306 million yuan, 68.38 million yuan, and 19.05 million yuan respectively [3]. - Conversely, the stocks with the highest net outflows included Artis, Lide Harmony, and Juguang Technology, with net outflows of 65.56 million yuan, 58.08 million yuan, and 32.03 million yuan respectively [3].
奕瑞科技现2笔大宗交易 总成交金额2.22亿元
(原标题:奕瑞科技现2笔大宗交易 总成交金额2.22亿元) | 成交 | 成交金 | | 相对当 | | | | --- | --- | --- | --- | --- | --- | | 量 | 额 | 成交价 | 日 | | | | (万 | (万 | 格 | 收盘折 溢价 | 买方营业部 | 卖方营业部 | | 股) | 元) | (元) | (%) | | | | 136.18 | 15118.47 | 111.02 | -3.30 | 高盛(中国)证券有限责任公司上海浦东 | 华泰证券股份有限公司成都 | | | | | | 新区世纪大道证券营业部 | 蜀金路证券营业部 | | 64.04 | 7109.78 | 111.02 | -3.30 | 高盛(中国)证券有限责任公司上海浦东 | 华泰证券股份有限公司成都 | | | | | | 新区世纪大道证券营业部 | 蜀金路证券营业部 | 奕瑞科技9月5日大宗交易平台共发生2笔成交,合计成交量200.22万股,成交金额2.22亿元。成交价格均 为111.02元,相对今日收盘价折价3.30%。 注:本文系新闻报道,不构成投资建议,股市有风险,投资需谨慎。 ...
奕瑞科技今日大宗交易折价成交200.22万股,成交额2.22亿元
Xin Lang Cai Jing· 2025-09-05 09:37
Group 1 - The trading date for the transactions is September 5, 2025, involving the company Yirui Technology (奕瑞科技) with the stock code 688301 [1] - The transaction price for Yirui Technology was 111.02 yuan, with a total transaction amount of 15,118.47 thousand yuan for one of the trades [1] - The trading volume for the same transaction was 136.18, indicating significant trading activity [1] Group 2 - Another transaction on the same date for Yirui Technology had a total transaction amount of 7,109.78 thousand yuan, maintaining the same transaction price of 111.02 yuan [1] - The trading volume for this second transaction was 64.04, reflecting continued interest in the stock [1]
奕瑞科技股价跌5.03%,天弘基金旗下1只基金重仓,持有18.3万股浮亏损失107.58万元
Xin Lang Cai Jing· 2025-09-04 06:33
Company Overview - Yirui Technology Co., Ltd. is located at 999 Huanqiao Road, Pudong New District, Shanghai, established on March 7, 2011, and listed on September 18, 2020 [1] - The company's main business involves the research, production, sales, and service of digital X-ray detectors [1] Revenue Composition - The revenue composition of Yirui Technology is as follows: - Detector sales account for 81.21% - Core component sales contribute 7.66% - Solutions/technical services generate 5.89% - Accessory sales make up 4.57% - Rental income is 0.66% [1] Stock Performance - On September 4, Yirui Technology's stock fell by 5.03%, closing at 111.00 CNY per share, with a trading volume of 257 million CNY and a turnover rate of 1.13%, resulting in a total market capitalization of 22.224 billion CNY [1] Fund Holdings - Tianhong Fund has a significant holding in Yirui Technology, with the Tianhong CSI Pharmaceutical 100A fund (001550) holding 183,000 shares, representing 1.09% of the fund's net value, making it the ninth-largest holding [2] - The Tianhong CSI Pharmaceutical 100A fund was established on June 30, 2015, with a latest scale of 755 million CNY [2] Fund Performance - The Tianhong CSI Pharmaceutical 100A fund has achieved a year-to-date return of 18.58%, ranking 2307 out of 4222 in its category, and a one-year return of 32.54%, ranking 2866 out of 3789 [2]